吃瓜大本营

On June 30, 2021, the U.S. District Court for the Southern District of Indiana granted plaintiffs' motion for a preliminary injunction, blocking the restrictions from taking effect. The case is currently scheduled for trial in August 2023.

There is no scientific evidence that a medication abortion can be halted after a patient has taken the first medication and leading medical organizations these requirements. Forcing providers to give their patients this misinformation is both unethical and unconstitutional; courts in North Dakota, Oklahoma, and Tennessee have blocked similar restrictions.

The lawsuit also challenges a 2021 ban on patients鈥� ability to obtain medication abortion via telemedicine. A nearly identical ban is already being considered by a federal district court judge in separate litigation 鈥� Whole Woman鈥檚 Health Alliance v. Rokita 鈥� challenging a host of abortion restrictions in Indiana.

These are not the only legal challenges to the myriad obstacles and indignities Hoosiers face when they need an abortion. Indiana鈥檚 web of abortion restrictions includes various Targeted Regulation of Abortion Provider (鈥淭RAP鈥�) laws; a ban on the standard method for abortion care starting in the earliest weeks of the second trimester; and a law restricting minors鈥� access to abortion.

The plaintiffs in this challenge include All-Options, Whole Woman鈥檚 Health Alliance, Planned Parenthood Great Northwest, Hawai鈥榠, Alaska, Indiana, Kentucky, Women鈥檚 Med Group Professional Corporation and individual physicians. They are represented by the Lawyering Project, Planned Parenthood Federation of America, the ACLU, the ACLU of Indiana, and Katherine D. Jack of the Jack Law Office LLC. The case was filed in the United States District Court for the Southern District of Indiana, Indianapolis Division.